vs

Side-by-side financial comparison of CREATIVE REALITIES, INC. (CREX) and Monte Rosa Therapeutics, Inc. (GLUE). Click either name above to swap in a different company.

CREATIVE REALITIES, INC. is the larger business by last-quarter revenue ($23.9M vs $12.8M, roughly 1.9× Monte Rosa Therapeutics, Inc.). CREATIVE REALITIES, INC. runs the higher net margin — -8.2% vs -212.1%, a 203.9% gap on every dollar of revenue. On growth, CREATIVE REALITIES, INC. posted the faster year-over-year revenue change (117.2% vs 38.5%). Monte Rosa Therapeutics, Inc. produced more free cash flow last quarter ($99.8M vs $-4.6M).

Creative Realities, Inc. is a provider of end-to-end immersive digital experience solutions, including interactive digital signage, content management software, and custom experiential design services. It primarily caters to retail, hospitality, healthcare, corporate workplace, and public sector clients across North America, helping brands enhance customer engagement and operational efficiency.

Monte Rosa Therapeutics is a clinical-stage biotechnology company specializing in the discovery and development of targeted molecular glue degrader therapies. Its pipeline addresses unmet medical needs across oncology, rare genetic disorders and immunological diseases, with operations focused on advancing novel treatments for global patient populations.

CREX vs GLUE — Head-to-Head

Bigger by revenue
CREX
CREX
1.9× larger
CREX
$23.9M
$12.8M
GLUE
Growing faster (revenue YoY)
CREX
CREX
+78.7% gap
CREX
117.2%
38.5%
GLUE
Higher net margin
CREX
CREX
203.9% more per $
CREX
-8.2%
-212.1%
GLUE
More free cash flow
GLUE
GLUE
$104.3M more FCF
GLUE
$99.8M
$-4.6M
CREX

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CREX
CREX
GLUE
GLUE
Revenue
$23.9M
$12.8M
Net Profit
$-2.0M
$-27.1M
Gross Margin
47.9%
Operating Margin
1.9%
-258.3%
Net Margin
-8.2%
-212.1%
Revenue YoY
117.2%
38.5%
Net Profit YoY
30.8%
-13.5%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CREX
CREX
GLUE
GLUE
Q4 25
$23.9M
Q3 25
$10.5M
$12.8M
Q2 25
$13.0M
$23.2M
Q1 25
$9.7M
$84.9M
Q4 24
$11.0M
$60.6M
Q3 24
$14.4M
Q2 24
$13.1M
Q1 24
$12.3M
Net Profit
CREX
CREX
GLUE
GLUE
Q4 25
$-2.0M
Q3 25
$-7.9M
$-27.1M
Q2 25
$-1.8M
$-12.3M
Q1 25
$3.4M
$46.9M
Q4 24
$-2.8M
$13.4M
Q3 24
$54.0K
Q2 24
$-615.0K
Q1 24
$-109.0K
Gross Margin
CREX
CREX
GLUE
GLUE
Q4 25
47.9%
Q3 25
45.3%
Q2 25
38.5%
Q1 25
45.7%
Q4 24
44.2%
Q3 24
45.6%
Q2 24
51.8%
Q1 24
46.9%
Operating Margin
CREX
CREX
GLUE
GLUE
Q4 25
1.9%
Q3 25
-68.9%
-258.3%
Q2 25
-10.2%
-67.1%
Q1 25
-7.4%
51.9%
Q4 24
-6.5%
21.4%
Q3 24
7.9%
Q2 24
4.5%
Q1 24
-0.6%
Net Margin
CREX
CREX
GLUE
GLUE
Q4 25
-8.2%
Q3 25
-74.5%
-212.1%
Q2 25
-13.9%
-53.0%
Q1 25
34.6%
55.2%
Q4 24
-25.8%
22.2%
Q3 24
0.4%
Q2 24
-4.7%
Q1 24
-0.9%
EPS (diluted)
CREX
CREX
GLUE
GLUE
Q4 25
Q3 25
$-0.75
Q2 25
$-0.17
Q1 25
$0.32
Q4 24
$-0.28
Q3 24
$0.01
Q2 24
$-0.06
Q1 24
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CREX
CREX
GLUE
GLUE
Cash + ST InvestmentsLiquidity on hand
$1.6M
$208.3M
Total DebtLower is stronger
$44.0M
Stockholders' EquityBook value
$21.5M
$245.8M
Total Assets
$151.0M
$459.8M
Debt / EquityLower = less leverage
2.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CREX
CREX
GLUE
GLUE
Q4 25
$1.6M
Q3 25
$314.0K
$208.3M
Q2 25
$569.0K
$69.4M
Q1 25
$1.1M
$78.5M
Q4 24
$1.0M
$224.3M
Q3 24
$868.0K
Q2 24
$4.1M
Q1 24
$2.9M
Total Debt
CREX
CREX
GLUE
GLUE
Q4 25
$44.0M
Q3 25
$22.0M
Q2 25
$19.9M
Q1 25
$23.0M
Q4 24
$13.0M
Q3 24
$10.7M
Q2 24
$13.6M
Q1 24
$12.8M
Stockholders' Equity
CREX
CREX
GLUE
GLUE
Q4 25
$21.5M
Q3 25
$21.9M
$245.8M
Q2 25
$29.4M
$268.1M
Q1 25
$29.9M
$275.2M
Q4 24
$25.5M
$222.9M
Q3 24
$28.3M
Q2 24
$28.2M
Q1 24
$28.8M
Total Assets
CREX
CREX
GLUE
GLUE
Q4 25
$151.0M
Q3 25
$61.3M
$459.8M
Q2 25
$63.7M
$359.6M
Q1 25
$67.0M
$393.2M
Q4 24
$65.2M
$438.7M
Q3 24
$67.6M
Q2 24
$69.6M
Q1 24
$68.2M
Debt / Equity
CREX
CREX
GLUE
GLUE
Q4 25
2.04×
Q3 25
1.00×
Q2 25
0.68×
Q1 25
0.77×
Q4 24
0.51×
Q3 24
0.38×
Q2 24
0.48×
Q1 24
0.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CREX
CREX
GLUE
GLUE
Operating Cash FlowLast quarter
$-4.5M
$100.4M
Free Cash FlowOCF − Capex
$-4.6M
$99.8M
FCF MarginFCF / Revenue
-19.1%
781.5%
Capex IntensityCapex / Revenue
0.4%
5.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.1M
$145.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CREX
CREX
GLUE
GLUE
Q4 25
$-4.5M
Q3 25
$-1.6M
$100.4M
Q2 25
$773.0K
$-34.7M
Q1 25
$-2.4M
$-45.5M
Q4 24
$-1.4M
$128.9M
Q3 24
$544.0K
Q2 24
$2.3M
Q1 24
$1.9M
Free Cash Flow
CREX
CREX
GLUE
GLUE
Q4 25
$-4.6M
Q3 25
$-1.7M
$99.8M
Q2 25
$672.0K
$-36.4M
Q1 25
$-2.5M
$-47.1M
Q4 24
$-1.4M
$128.7M
Q3 24
$543.0K
Q2 24
$2.3M
Q1 24
$1.9M
FCF Margin
CREX
CREX
GLUE
GLUE
Q4 25
-19.1%
Q3 25
-16.2%
781.5%
Q2 25
5.2%
-157.0%
Q1 25
-25.2%
-55.4%
Q4 24
-12.5%
212.3%
Q3 24
3.8%
Q2 24
17.3%
Q1 24
15.7%
Capex Intensity
CREX
CREX
GLUE
GLUE
Q4 25
0.4%
Q3 25
1.0%
5.1%
Q2 25
0.8%
7.3%
Q1 25
0.1%
1.9%
Q4 24
0.0%
0.3%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
CREX
CREX
GLUE
GLUE
Q4 25
Q3 25
Q2 25
Q1 25
-0.73×
-0.97×
Q4 24
9.59×
Q3 24
10.07×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CREX
CREX

Service And Other$17.3M72%
Managed Services$4.7M20%
Installation Services$1.7M7%

GLUE
GLUE

Segment breakdown not available.

Related Comparisons